Oncopeptides AB Long-term Investment Intensity
Oncopeptides AB long-term investment intensity. Oncopeptides AB (ONCO) has a Long-term Investment Intensity of 0.3% as of December 2019. Long-term investments of Skr3.30 Million represent 0.3% of total assets of Skr993.49 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Oncopeptides AB (ONCO) total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Oncopeptides AB (2017–2019)
Long-term investment intensity of Oncopeptides AB from 2017 to 2019. This chart shows how Oncopeptides AB's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2019. As of December 2019, the intensity stands at 0.3%, reflecting long-term investments of Skr3.30 Million against total assets of Skr993.49 Million SEK.
Oncopeptides AB Long-term Investment Intensity by Year (2017–2019)
Oncopeptides AB long-term investment intensity by year from 2017 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Oncopeptides AB from 2017 to 2019, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ONCO current and non-current assets.
| Year | LT Investment Intensity | LT Investments (SEK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.3% | Skr3.30 Million | Skr993.49 Million | ▲ +0.3 pp |
| 2017 | 0.1% | Skr263.00K | Skr479.82 Million | — |